Background Antibiotic resistant bacterial nosocomial infections are a leading problem in intensive care units (ICU). Objective 12(20.33%) in 2010, 2(20%) in 2011 and 13(25%) in 2012. only collistin sensitive organism identified was 28(23.14%).

Background: Sepsis occurs due to different sources of infection. Objective: The purpose of the present study was to see the demographic profiles and sources of infection among septic patients admitted at ICU of a public hospital in Dhaka City. Methodology: This descriptive cross sectional study was conducted in the Intensive Care Unit of the department of Anaesthesia Analgesia, Palliative and Intensive Care Medicine, Dhaka Medical College Hospital, Dhaka, Bangladesh over a period of 12 months starting from January 2016 to December 2016. All patients admitted to ICU with the features of severe sepsis and septic shock according to SSC guidelines with the age of more than or equal to 18 years in both sexes were set as selection criteria for this study. Instruments required to perform the study were data sheet addressing the demographic data, primary source of severe sepsis and organ dysfunctions. BSepsis was confirmed by detection of serum lactate and culture of blood. Result: A total number of patients was 69 cases. The mean with SD was 38.72 ±13.43 with the age range of patient 18 to 65 year. The male and female ratio was 1.7:1. The most common source of infection were abdomen which was 30(43.5%) cases followed by CNS, respiratory tract, urogenital tract and GIT which were (21.7%) cases, (14.5%) cases, (17.4%) cases and (2.9%) cases respectively. Among the 69 patient 20 patients were blood cultures positive, 15 patients were pus culture positive, 10 patients were urine/catheter tip culture positive. Conclusion: In conclusion young adult male is most commonly suffering from sepsis in ICU mostly due to infection of abdomen. Bangladesh Journal of Infectious Diseases 2020;7(2):40-43

Medication error is a major cause of morbidity and mortality in medical profession . There is an increasing recognition that medication errors are causing a substantial global public health problem, as many result in harm to patients and increased costs to health providers.Anaesthesia is now safe and routine, yet anaesthetists are not immune from making medication errors and the consequences of their mistakes may be more serious than those of doctors in other specialties. Steps are being taken to determine the extent of the problem of medication error in anaesthesia. In this review, incidence, types, risk factors and preventive measures of the medication errors are discussed in detail.Journal of Bangladesh Society of Anaesthesiologists 2014; 27(1): 31-35

No abstract

Background: Hypertension has been reported as the most prevalent comorbidity in patients with corona virusdisease 2019 (COVID-19) .Since hypertension is exceedingly frequent in the elderly and older people appear tobe at particular risk of being infected with SARS-COV-2 virus and of experiencing severe forms andcomplications of COVID-19. Objective : This retrospective study aim to compare the outcomes in COVID-19 infected patients with orwithout hypertension. Method : Atotal 180 hospitalized patients with laboratory confirmed COVID-19 were included. The medicalrecord including clinical feature, history of hypertension were included in this study. This study wasconducted in COVID-19 ICUof Bangabandhu Sheikh Mujib Medical University from August 2020 to January2021.Informationwere obtained frommedical record including clinical features, complication,treatments andclinical outcome were extracted for the analysis. Results: There were 180 patients selected for this study. 50(27.8%) patients had 51-60 years ,79(43.5%)patients had61-70 years and 27(15%) patients had 71-80 years.This study showed that 71.7% patients washypertensive and 29.3% patients was non-hypertensive. In total 180 patients, mortality rate was 65.1% inhypertensive patientsand mortality rate was41.1% in non-hypertensivepatients.Among them patientscomorbidity was 50% Diabetes mellitus,14% Bronchial asthma,14% patients Ischemic heart disease, 11%Chronic Kidney disease ,6% hypothyroidism and 5% cerebrovascular disease. Conclusion: This study concluded that hypertension does not affect the outcome of COVID-19. Compared withthe group of survivors and non-surviving COVID-19 patients with hypertension, most of the patients were olderand had more comorbidity. JBSA 2021; 34 (2) : 44-48